Researchers have made a significant breakthrough in developing a new gene therapy approach that restores full-length dystrophin protein, which could lead to new treatments for people with Duchenne muscular dystrophy (DMD).
Categories
Recent Posts
- Izzy Camilleri Merges High Fashion and Adaptive Clothing Design
- My late brother was my greatest teacher, in life and Duchenne
- LGMD gene therapy gets FDA orphan drug designation
- Capricor plans Deramiocel resubmission to the FDA, pursuing both cardiac and skeletal muscle indications in Duchenne
- MDA Ambassador Guest Blog: Life Lessons on My Journey with Becker Muscular Dystrophy